OMEN CDP 40

About

Omen CDP 40 is a combination medication containing Olmesartan, an angiotensin II receptor blocker (ARB), and Cilnidipine, a dihydropyridine calcium channel blocker (CCB). This formulation is primarily indicated for the treatment of essential hypertension. Olmesartan works by blocking the action of angiotensin II, a potent vasoconstrictor, leading to relaxation of blood vessels and a reduction in blood pressure. Cilnidipine, a unique L/N-type calcium channel blocker, further contributes to blood pressure reduction by causing peripheral arterial vasodilation and reducing sympathetic nerve activity.

The combined action of these two agents provides comprehensive and sustained blood pressure control, often more effectively than either agent alone, especially in patients whose blood pressure is not adequately controlled by monotherapy. This combination helps to lower the risk of cardiovascular complications such as stroke and myocardial infarction associated with uncontrolled high blood pressure. It is typically administered once daily, offering convenience and promoting patient adherence.

Uses

• Treatment of essential hypertension.
• Management of high blood pressure in adults.
• Reduction of cardiovascular risk in hypertensive patients.
• When monotherapy with either olmesartan or cilnidipine is insufficient.

Directions For Use

Take this medication orally, usually once daily, with or without food, as directed by your physician. Swallow the tablet whole with water.

Benefits

• Effective and sustained blood pressure reduction.
• Dual mechanism of action for comprehensive control.
• Reduces risk of cardiovascular events.
• Convenient once-daily dosing.
• May reduce sympathetic overactivity.
• Improved patient adherence.

Side Effects

• Dizziness or lightheadedness
• Headache
• Ankle swelling (edema)
• Fatigue
• Flushing
• Palpitations
• Nausea
• Abdominal pain
• Orthostatic hypotension
• Bradycardia
• Hyperkalemia (due to olmesartan)
• Renal impairment (rare)

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can enhance the blood pressure-lowering effect, leading to increased dizziness or lightheadedness.
• Pregnancy - Contraindicated during the second and third trimesters due to potential fetal harm (renal dysfunction, oligohydramnios, fetal death). Consult a doctor immediately if pregnant.
• Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk and potentially harm the infant. Consult your doctor.
• Liver - Use with caution in patients with liver impairment, as dosage adjustments may be necessary. Close monitoring of liver function is advised.
• Kidney - Use with caution in patients with kidney impairment. Regular monitoring of kidney function and serum potassium levels is essential.
• Lung - Generally considered safe for use in patients with lung conditions. However, monitor for any unusual symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.